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Researchers’ and Clinicians’ Perceptions of Recruiting 
Participants to Clinical Research: A Thematic 
Meta-Synthesis
Lisa Newingtona, c, Alison Metcalfeb
Abstract
Background: Recruiting the desired number of research partici-
pants is frequently problematic with resulting financial and clinical 
implications. The views of individuals responsible for participant 
recruitment have not been previously reviewed. This systematic 
review and thematic meta-synthesis explores researchers’ and cli-
nicians’ experiences and perceptions of recruiting participants to 
clinical research, with the aim of informing improved recruitment 
systems and strategies.
Methods: Studies published between January 1995 and May 2013 
were identified from: Ovid MEDLINE, Ovid EMBASE, Ovid 
PSYCHINFO, ASSIA, British Nursing Index, Scopus, Web of Sci-
ence, CINAHL and PubMed. Included studies were original peer 
reviewed research, with qualitative methodologies and an aim of 
exploring the views of clinicians and/or researchers on recruitment 
to clinical research. Studies discussing the recruitment of patients 
unable to give informed consent were excluded. The findings sec-
tions of the relevant studies were free coded to identify key con-
cepts which were grouped into hierarchical themes. The quality of 
the identified studies was assessed and the relative contribution of 
each paper was checked to ensure individual studies did not domi-
nate in any theme.
Results: Eighteen relevant papers were identified which examined 
the views of researchers and clinicians in 10 clinical specialties. 
Five main themes emerged: building a research community, secur-
ing resources, the nature of research, professional identities and re-
cruitment strategies. The views of researchers and clinicians were 
similar, although the role of ‘researcher’ was inconsistently defined.
Conclusions: The general experience of recruiting participants to 
clinical research was one of competition and compromise. Com-
petition arose over funding, staffing and participants, and between 
clinical and research responsibilities. Compromise was needed to 
create study designs that were acceptable to patients, clinicians and 
researchers. Forging relationships between clinical and research 
teams featured extensively, however the involvement of patients 
and the public within the research community was rarely discussed.
Keywords: Research subject recruitment; Research personnel; 
Medical staff; Systematic review
Introduction
The concept of evidence-based practice in healthcare neces-
sitates the completion of robust research in answer to im-
portant clinical questions. However, not all studies are able 
to recruit a sufficient number of participants to adequately 
answer their research question in the allocated time-period, 
raising issues of resource usage and delaying changes to 
practice. Only 31% of a cohort of UK-based multicentre tri-
als conducted between 1994 and 2002 achieved their original 
recruitment target [1], and this situation is not unique to the 
country, study design or clinical area [2, 3].
A recent systematic review and meta-analysis of strate-
gies to improve recruitment to randomized controlled trials 
(RCTs) found 45 studies exploring this issue [4]. The major-
ity of studies involved strategies aimed at potential trial par-
ticipants, such as comparisons of different information deliv-
ery formats or consent processes. The remaining four studies 
assessed the effect of greater contact between the central trial 
team and the recruiting sites [5, 6] or the use of recruitment 
training packages [7, 8], but none of these interventions were 
associated with significant increases in the number of partici-
pants recruited.
The reasons why some individuals consent to participate 
in clinical research whilst others decline are rapidly being 
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explored. Proposed factors include age [9], ethnicity [10], 
availability of healthcare [11] and health beliefs [12]. Inter-
views with research participants have shown different levels 
of research awareness prior to taking part, identified mixed 
experiences of participation and raised varied suggestions of 
ways to improve recruitment [13]. Increasing participation 
in clinical research is recognized as a key agenda within the 
NHS to facilitate evidence-based policy, improve health out-
comes and reduce inequality [14]. The ‘OK to ask’ [15] and 
‘get randomized’ [16] campaigns have been launched to pro-
mote public awareness of research and encourage patients to 
discuss research opportunities with their clinicians.
For the clinicians responsible for recruiting patients 
to clinical research, additional workloads, financial losses, 
conflicts of interest and lack of knowledge about the indi-
vidual study have all been discussed as barriers to successful 
research [17, 18]. Conversely, financial incentives, positive 
attitudes towards research, relevance to their patients and ef-
fective information technology systems have been proposed 
as facilitators [19]. To date, the views of research teams 
working in different clinical specialities, and on studies of 
different designs, have not been systematically reviewed and 
synthesized, with much of the existing literature focusing on 
RCTs [4, 20]. It is hoped that the identification and synthe-
sis of experiences across different study designs will enable 
better understanding of the issues involved in participant re-
cruitment and inform improvements in general recruitment 
systems and strategies. This review therefore posed the fol-
lowing question: what are researchers’ and clinicians’ expe-
riences and perceptions of recruiting participants for clinical 
research?
Methods
Empirical studies exploring researchers’ and/or clinicians’ 
views of recruitment to clinical research were systematically 
identified and the findings from relevant papers were com-
bined in a thematic synthesis based on the process outlined 
by Thomas and Harden [21]. Several survey-based studies 
have been conducted to determine the views of clinicians on 
various aspects of clinical research, for examples see King et 
al [22], Meropol et al [23] and Ford et al [24], however it was 
chosen to limit the current review to qualitative research to 
allow a less structured and more in-depth exploration of the 
phenomena involved. Where studies adopted a mixed meth-
ods approach, only the findings from the qualitative aspect 
were included in this review.
Search strategy
Relevant articles published between January 1995 and May 
2013 were identified by the primary author using electronic 
databases, hand-searching the references of eligible papers 
and free internet searches [25]. Search terms are listed in 
Figure 1, with the full strategy shown in Supplementary 
1 (www.jocmr.org). This process was duplicated and re-
viewed by the second author. The lower boundary of 1995 
was chosen because substantial changes to the NHS research 
structure were introduced after the 1994 Culyer report [26]. 
Changes to USA research processes also arose during this 
period following lobbying from patient groups concerned 
about research accessibility and regulatory delays [27]. This 
changing context is also likely to apply to other jurisdictions 
and it was felt that earlier research may not adequately re-
flect the current situation. Figure 1 shows a flowchart of the 
identification and selection process including the inclusion 
and exclusion criteria and the numbers eliminated at each 
stage. Relevant articles were original peer reviewed studies 
reporting qualitative research that explored the views of re-
searchers and/or clinicians on the recruitment of participants 
for clinical research. Clinical research was defined as any 
medical research requiring consent to participate, including 
the donation of tissue samples, observational studies and 
clinical trials. Studies discussing the recruitment of individu-
als who may not have capacity to give informed consent, 
such as children, intensive care patients or those with mental 
health issues, were excluded due to the additional ethical is-
sues surrounding the recruitment of these populations [28]. 
The included papers were limited to English language.
Assessment of quality
The assessment of quality in qualitative research has received 
much debate and agreement on the most suitable method has 
not been reached [29]. To allow the systematic identifica-
tion of study weakness, methodological flaws and missing 
information, eligible articles for this review were assessed 
for quality using the CASP checklist [30]. The aim was not 
to exclude studies on grounds of quality, rather to allow an 
assessment of the impact of study quality on the review’s 
findings [21]. After the thematic synthesis was complete, the 
relative contribution of the included studies was assessed to 
ensure that the key aspects of the analytic themes were not 
derived from a small number of papers, or papers of poorer 
quality.
Analysis
All relevant articles were imported into NVivo (QRS, ver-
sion 10) and the qualitative findings for each were free coded 
line-by-line to identify the key concepts. The similarities, 
differences and links between the resulting codes were used 
to form groups of codes and create a hierarchical structure 
representing distinct themes [21]. Consistency was checked 
at each stage by reviewing the codes against the original text 
and re-coding earlier codes where appropriate. The initial 
findings were organized according to the identified themes 
162                                                                                                                                                                                                                                                                                                                                                                                                                                             163
J Clin Med Res. 2014;6(3):162-172   Recruiting Participants to Clinical Research
Articles © The authors   |   Journal compilation © J Clin Med Res and Elmer Press Inc™   |   www.jocmr.org
and discussed by both authors prior to the development of 
the final version.
 
Results
A total of 18 studies were included in the review [31-48], the 
details are outlined in Supplementary 2 (www.jocmr.org). 
Oncology was the most frequently mentioned clinical spe-
cialty [32, 34, 35, 38, 41, 43, 45, 48] and clinical trials were 
the most common type of research discussed [32, 34, 35, 37, 
38, 41, 43-46, 48]. The term ‘researcher’ was not clearly de-
fined, with some studies combining the views of recruiting 
doctors and nurses, principal investigators and trial manag-
ers [34], others looking solely at the perspectives of research 
assistants or associates [33, 38, 48], and others exploring the 
Figure 1. Search strategy and identification of studies included in the review.
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experience of research nurses [35, 44, 47] or scientists [40]. 
Similarly, the studies focused on a range of clinicians, in-
cluding pharmacists [36], doctors [31, 32, 37, 41, 43, 44], 
midwives [39], nurses [46] and the whole multi-disciplinary 
team [45]. For this reason, it was not possible to differenti-
ate the views of researchers and clinicians throughout, but 
where possible this has been discussed.
Researchers’ and clinicians’ experiences and percep-
tions of recruiting participants for clinical research centered 
around five main themes: building a research community, 
securing resources, the nature of research, professional iden-
tities and recruitment strategies.
Building a research community
It was widely recognized that successful clinical research 
could not be a unilateral activity. Both researchers and clini-
cians acknowledged the need to engage all relevant parties 
(researchers, clinicians, patients and public) in discussions 
regarding research aims and practices [31, 32, 34, 39, 40, 
42, 43, 45, 47] and overall there was a common belief that 
clinical research was necessary to generate improvements in 
patient care. However, despite this shared goal, it appeared 
that the idea of collaborative research communities was 
more theoretical than established. For some clinicians, there 
appeared to be a disconnect between the belief that clini-
cal research was required and the desire to be personally in-
volved. Reasons included a perceived lack of resources [31, 
34, 38, 43, 46], issues with the study question or design [38, 
43], concerns that patients would ask questions outside the 
clinician’s knowledge base [36, 39] and the need to prioritize 
patient care [37, 39]. To counter this potential lack of inter-
est, researchers saw it as their role to engage clinicians in 
each piece of research, to persuade them of its relevance and 
to encourage recruitment [34, 37, 40, 42, 47].
The benefit of being involved in a research community 
was felt by both professional groups. Where the clinicians 
had been actively engaged in the research decision-making 
the studies appeared well supported by clinicians [34, 40, 
47]. The reverse was also true [43]. The formation of col-
laborative ties between researchers and clinicians was seen 
to create a sense of loyalty to the project, which in turn aided 
recruitment [34]; previous alliances and positive experienc-
es were also viewed as beneficial [34, 37, 45, 46]. Less at-
tention was given to establishing a collaborative relationship 
with the local population or target patient groups. Research-
ers from studies involving minority groups highlighted the 
value of pre-research trust-building activities, such as free 
screening sessions, holding meetings in the local community 
and involving key community members in research design 
and recruitment [35, 37].
The flow of information from the main study team to cli-
nicians and participants was also viewed as part of the collab-
orative process. Keeping the recruiting clinicians informed 
of the research project was seen to facilitate recruitment by 
maintaining interest in the study [32, 46] and by boosting 
competition between recruiting sites [44]. Providing insuf-
ficient information to clinicians was viewed negatively and 
regarded as a lack of appreciation of their contribution [39]. 
Furthermore, both professional groups emphasized the im-
portance of feeding back research findings to all parties and 
ensuring the results were used to improve patient care [31, 
32, 39].
Securing resources
Sufficient and appropriate resources were seen as an inte-
gral part of a successful research community. Money, staff, 
time and patients were all viewed as scarce commodities and 
strategies to secure them were generally seen as beneficial 
to recruitment. For researchers, there was a double aspect to 
recruitment: recruiting the appropriate healthcare teams or 
clinicians, who could then recruit eligible patients. In order 
to gain the support of clinical teams, it was essential that 
research collaboration did not impose additional financial 
costs or increase workloads [34, 43]. Providing a sufficient 
number of well-trained staff was therefore seen as central to 
the successful running of clinical research projects [42, 45].
Both researchers and clinicians recounted the limited 
scope of public funding, and obtaining financial support 
from commercial companies was seen as an important re-
source [34, 44]. Commercial funding was believed to facili-
tate patient participation by enabling compensation for all 
research costs, such as parking and childcare [38] and to aid 
the development of dedicated research teams through the 
creation of salaried research positions and the purchase of 
equipment or training not available through healthcare bud-
gets [44]. However, researchers and clinicians were wary of 
the potential loss of control associated with commercially 
driven interests and the appeal of commercial funding was 
tempered by the need to maintain scientific and ethical integ-
rity [34, 39, 44].
Eligible patients were also viewed as a scarce resource, 
creating competition between academic and commercially 
funded research for the recruitment of specific patient popu-
lations [41]. Competition between centers was mentioned as 
a driving force for recruitment [44], although professional 
rivalry was seen to prevent cooperation thereby reducing 
overall recruitment [43].
Nature of the research
The focus of the research was identified as a key factor in 
determining the recruiters’ contribution to a particular study 
[32, 34, 36-38, 40, 41, 43-45, 48]. Building collaborative 
research communities may aid the development of research 
questions that are truly relevant to clinicians and their pa-
tients; however, as discussed previously, it was important 
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not to allow commercial agendas to dominate [34]. A con-
flict also arose between the use of a scientifically desirable 
study design and the creation of a study that was acceptable 
to recruiters and potential participants [34, 37, 38, 40]. There 
was agreement that RCTs were the gold standard for clinical 
effectiveness research, although several clinicians expressed 
concern about randomly allocating treatment, especially in 
the absence of clinical equipoise [31, 32, 43, 45]. There were 
fewer issues with the research design for other methods [39, 
40, 42], possibly because clinicians had control over treat-
ment decision making in these cases.
In addition to valuing the research question and accept-
ing the study design, researchers and clinicians must also be 
prepared to follow the study protocol. Clinicians from one 
study admitted deviating from the protocol in an attempt to 
prevent attrition and achieve good outcomes, despite under-
standing the impact this had on the robustness of the research 
and extrapolation of the findings [44]. These clinicians were 
driven by competition with other recruiting centers, the de-
sire to gain future commercial funding and the belief that 
certain patients would benefit from additional treatment [44].
Suggestions for more user-friendly research for both 
clinicians and participants included adopting flexible study 
designs, such as those that allow placebo and control groups 
to have access to the intervention at a later stage [34], early 
discussion of the exclusion criteria to avoid patient disap-
pointment after expression of interest [33], providing study 
interventions in-house, rather than sending patients to an 
external clinic [37], combining different study methods and 
approaches [42], creating a smooth and easy system for trial 
recruitment [38], having realistic recruitment targets [43] 
and avoiding intensive research protocols and tight time 
schedules [38].
Research regulations were seen as a necessary require-
ment to ensure good and ethical research practice, although it 
was hinted by both professional groups that these regulations 
were becoming excessive and a balance needed to be struck 
between protecting research participants and hindering ben-
eficial research [38, 40-43]. The importance of informed 
consent and voluntariness were stressed by all studies and 
there was awareness that contextual aspects, such as the way 
a recruiter informs a patient and the situation in which re-
cruitment occurs are influential to the potential participant’s 
decision [31, 32, 38, 39, 45, 48]. Problems were reported 
by clinicians who needed to inform patients and obtain their 
consent in a short timeframe [39], research assistants who 
felt that patients were too overloaded with information [33, 
38] and multi-disciplinary teams who identified variations in 
the approach and effectiveness of ‘selling’ the trial to eligible 
patients [45].
Professional identities
The distinction between researcher and clinician was not 
clear-cut, with clinical consultants acting as principal inves-
tigators and research nurses also having clinical responsibili-
ties. These interlinking roles and responsibilities were seen 
as a dual identity of healthcare provider and researcher [34, 
37]. Some individuals found this situation difficult to recon-
cile and remained suspicious of research, viewing it as an ad-
ditional burden and a competitor for their patients’ attention 
[34, 36, 37, 43]. However, the majority welcomed the oppor-
tunity to be involved in the progression of clinical practice 
and also saw participation in research as providing patient 
benefit [34, 35, 43-48]. Researchers and clinicians viewed 
research involvement as an opportunity for personal career 
progression or to improve institutional status [40, 41, 44], 
however, some researchers commented on the lack of career 
structure and difficulty retaining experienced staff [42].
For healthcare professionals, the responsibility of being 
a patient advocate was central in their decision to approach a 
patient about research participation [32, 34, 37]. Where cli-
nicians also held a principal investigator role, some reported 
a desire to delegate recruitment and retention activities to 
those with less of a stake in the project, such as research 
nurses, to minimize their conflicting responsibilities [44]. 
There were blurred boundaries between patient advocate and 
gatekeeping [42], with all recruiters reporting an element of 
gatekeeping for practical reasons, or because of their own 
implicit beliefs about the best interests of the patient, or in 
some cases, the best interests of the research. Reasons for 
limiting the inclusivity of recruitment included: concerns 
about the length of time it would take to explain the research 
because of language or psycho-social issues [38], an over 
emphasis on the vulnerability of the patient [42], concerns 
about gaining informed consent due to the educational level 
of the patient [43], perceived differences between eligibil-
ity criteria and patient suitability [41, 43, 46], cherry-pick-
ing patients to increase the chance of good outcomes [44], 
avoiding patients thought to be unreliable [44], deliberately 
choosing patients perceived as less compliant [46], avoid-
ing patients already receiving a lot of care [46], fear of be-
ing regarded as coercive [45], the loss of personal equipoise 
[32], a general lack of enthusiasm about the research [48] 
and simply forgetting to ask [36, 39]. It was only a minority 
view that all patients are, and should be, free to make their 
own decision about research participation [32, 46].
Across the included studies, the responsibility for in-
viting patients to participate rested predominantly with the 
clinicians. It was emphasized that those involved in recruit-
ment should have appropriate knowledge, including details 
of the research project and relevant regulations [33, 34, 40, 
41]. There were instances where the recruiting clinicians felt 
they had too little or superficial information [39], while in 
other settings they felt more adequately prepared [46, 47]. 
It was argued for one study that researchers would be more 
appropriate recruiters given their knowledge of the aims and 
intricacies of the research [39, 40]. However, where research 
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assistants were responsible for recruitment, they reported 
feeling ill-equipped to answer the patients’ medical ques-
tions and would have preferred clinician involvement [33].
Recruitment strategies
Clinicians and researchers held similar views of the reasons 
why patients accept the invitation to participate in clinical 
research. Altruism was believed to be the main motivator, 
with the desire to help future generations [31, 32, 38, 42, 47] 
and the wish to give something back to their healthcare team 
[42] cited as potential explanations. Other proposed reasons 
included financial reimbursement [33, 38], the belief that 
participation will be personally beneficial, such as access to 
regular monitoring, access to new treatments or the chance 
of a cure [38, 45], or being in a situation with limited treat-
ment options [48].
Suggested explanations of why patients decline to par-
ticipate in clinical research were similar across both profes-
sional groups. Reasons included: a distrust of research and 
concerns about being a guinea pig [37, 38], disliking the idea 
of receiving a placebo [43, 48], having strong preferences 
for a particular treatment [43, 45] and issues with the ad-
ditional time required for research participation, especially 
for patients with family or work commitments [38, 42, 47] 
or those living further away from the clinic [45]. In addition, 
one study found that eligible patients were reluctant to par-
ticipate if they did not personally define themselves as suf-
fering from the medical condition under investigation, whilst 
others felt that younger patients were more fearful and took 
longer to come to terms with their diagnosis making them 
harder to recruit [34].
The patient’s doctor [38, 47, 48], their family [38, 47] 
and the recruiting clinician [38, 40, 43, 45, 48] were all be-
lieved to make positive or negative contributions to recruit-
ment, depending on their personal attitudes towards clinical 
research and their opinions of the particular study in ques-
tion. Similarly, the effect of the media was variable depend-
ing on the nature of the coverage and general perceptions of 
the trustworthiness of the source [31, 37, 38, 48].
Numerous recruitment practices and strategies were dis-
cussed in the included studies. These strategies were broadly 
divided into three categories: emphasizing the benefits of re-
search participation, engendering trust in the research and 
establishing effective systems for the recruiters, as shown in 
Table 1.
Assessment of quality
The quality appraisal of the included studies is available in 
Supplementary 3 (www.jocmr.org). All themes were a com-
posite of the findings of several studies and no one study 
was found to dominate. Studies of lower quality tended to 
have fewer participants and provided insufficient informa-
tion about the data collection and analysis process.
Discussion
  
This review has synthesized the perceptions and experiences 
of researchers and clinicians involved in recruiting partici-
pants to clinical research across a range of study designs, 
locations and clinical specialties. Despite these contextual 
differences, five common themes were identified: building 
a research community, securing resources, the nature of re-
search, professional identities and recruitment strategies. 
While there were some differences in the issues highlighted 
by those working on different study designs, for example 
concerns about randomization and equipoise were only men-
tioned by those working on RCTs, none of the themes were 
dominated by reference to a particular study design. The cur-
rent review also indentified an overall consensus between 
the perceptions and experiences of clinicians and research-
ers, which was unexpected given previous reports of the dif-
ficulty engaging clinicians in research recruitment [18, 49]. 
This finding may in part be explained by the overlapping 
roles of healthcare researcher and clinician, an issue which 
has also been recognized previously [50]. Alternative meth-
ods of reporting the opinions of those involved in recruiting 
participants for clinical research may be more informative, 
such as making a distinction between those who usually see 
the patient for routine clinical care and those only involved 
in the research study. However, this distinction was not eas-
ily identified across the studies included in the current re-
view. One activity that was more commonly associated with 
researchers was the initial task of recruiting clinical teams 
to participate in their work. This was intricately linked to 
participant recruitment through the accepted influence of the 
clinician-patient relationship in a patient’s decision to take 
part, plus the more practical need to ensure that eligible pa-
tients were actually invited [51]. A recent systematic review 
of strategies aimed at improving clinician recruitment activi-
ties found the most promising interventions were aimed at 
increasing clinician research knowledge and engaging them 
in the recruitment process [20]. This mirrors the findings 
of the current review, where the idea of building a research 
community was seen as facilitating the continued interest of 
clinical teams thereby improving their participation in the 
whole research process.
It was evident that there were multiple instances where 
eligible patients were denied the opportunity to make their 
own decision about participating in clinical research. This 
did not solely take the form of clinician gatekeeping, which 
has been previously identified as problematic [52], but there 
were numerous instances where additional criteria were also 
applied by researchers to make a judgment on a patient’s 
suitability for their research. While this introduces the pos-
sibility of selection bias and reduces the generalizability 
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of the findings [53], it is also inequitable. In England, the 
NHS Constitution pledges to “inform you of research stud-
ies in which you may be eligible to participate” [54]. From 
the studies included in this review, it appears that this may 
not always be the case and that more should be done to en-
sure potentially eligible patients are given the opportunity to 
make their own decision about research participation. The 
previously mentioned ‘Ok to ask’ and ‘get randomized’ cam-
paigns are examples of this strategy and monitoring their ef-
fectiveness may aid the development of similar approaches 
elsewhere [15, 16].
There were no universally adopted recruitment strat-
egies. This mirrors the findings of Treweek et al [4], who 
identified a range of techniques across studies specifically 
investigating optimal recruitment methods. Within the cur-
rent review, the majorities of recruitment techniques were 
classified as attempts to engender patient support and were 
predominantly targeted at the individual patient level. Re-
searchers and clinicians working with minority groups did 
highlight the importance of engaging their whole population, 
as have authors elsewhere [10, 55], but this concept was not 
discussed more widely. Traditionally, members of minority 
groups have been considered more difficult to recruit to clin-
ical research, but throughout the studies reviewed all patients 
were viewed as a scarce resource. It is therefore surprising 
that more attention was not given to building a collaborative 
research community of clinicians, researchers and patients.
Altruism was suggested as the key principle explaining 
why patients decide to participate in clinical research. The 
significance of altruism and research participation has been 
discussed elsewhere and it is proposed that altruism is rarely 
the main motivational factor, with self-interest, encourage-
ment from family and friends, and a sense of obligation to 
the study team also important [12, 56-58]. As the current re-
view explored the opinions of recruiters, rather than research 
participants, it may be that the premise of altruistic research 
participation is a more idealistic than accurate interpretation 
of patients’ reasoning. However, research participants may 
also present a more idealistic view when questioned about 
their motivation for taking part [59]. The suggested domi-
nance of altruistic motives contrasts with a key recruitment 
strategy also indentified in the current review: emphasizing 
the benefits of research participation. This inconsistency 
hints at disconnect between the recruiter’s theoretical view 
of research participation and the day-to-day practicalities of 
actually recruiting participants, a finding that warrants fur-
ther investigation. The explanations given for patients de-
clining to participate were a combination of logistical fac-
tors, such as a lack of time, in addition to more overarching 
concerns about the research process. This is consistent with 
other findings [51]. Greater involvement of patients and the 
public in research design and planning could help allay con-
cerns about the processes of clinical research and thereby 
improve participation, but time will always be a barrier. The 
provision of financial compensation for the time involved in 
research participation may help offset this issue [4, 60, 61].
Strengths and limitations
This review adds a new perspective by identifying and syn-
thesizing the views of researchers and clinicians responsible 
for recruiting participants to research in different clinical 
areas, using different study designs. The implications for 
clinical research practice include the recommendation to 
ensure sufficient patient and public involvement within the 
research community, and the need to further explore more 
user-friendly research practices for both recruiters and par-
ticipants.
The included studies contained the views of an array of 
clinicians and researchers; however the distinction between 
the two was less clear-cut than expected. Further work to in-
vestigate the recruitment practices and experiences of those 
usually involved in patient care and those solely working on 
a research project may shed more light on the perceived dif-
ferences between patient advocates and gatekeepers.
The current review only included qualitative material. 
Several authors have published survey data in this field [22-
24] and incorporating these findings in a mixed-methods 
review may provide additional themes. Furthermore, the 
included studies were limited to English language. The re-
moval of this restriction may have enabled the identification 
of studies from a broader range of geographical locations; 
however preliminary work suggested a lack of relevant pub-
lications in alternative languages.
Conclusions
The general experience of recruiting participants to clinical 
research was one of competition and compromise. Competi-
tion took the form of attracting sufficient funding, staff and 
participants, in addition to competing clinical and research 
responsibilities. Compromise was needed to create study 
designs that were acceptable to all involved, and to allow 
cooperation between commercial and academic institutions. 
Forging relationships between clinical and research teams 
featured extensively, however patient and public involve-
ment in the research community was rarely discussed. De-
spite differences in location and healthcare systems, there 
were similarities between the reported recruitment experi-
ences in all included studies. Whilst this hints at a common 
picture, given the majority of studies were located in Europe 
or North America, further work is required to assess the situ-
ation elsewhere.
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